Non-CME Corporate Forum sponsored by AstraZeneca.

Dinner will be provided.

The Non-CME Corporate Forum content and views expressed therein do not necessarily reflect the views, policies or position of the American College of Allergy, Asthma & Immunology.

There is no registration fee for attending this Non-CME Corporate Forum; however, seating is limited. Preregistration does not guarantee seating. We recommend arriving at the meeting room early.

Prefer to participate online? Register for our live stream at ExchangeCME.com/CRSwNPBostonLivestream.

Target Audience

The design of this activity addresses the needs of clinical immunologists/allergists, ear, nose, and throat (ENT) specialists, and pulmonologists who manage patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Program Overview

Don’t miss this Medical Jeopardy™ activity, led by our expert faculty, designed to provide an informative and engaging approach to learning about chronic rhinosinusitis with nasal polyps (CRSwNP)! Topics covered include pathophysiology, assessment of phenotypes and disease burden, and the rationale and evidence behind available and emerging biologic therapies.

Learning Objectives

After completing this activity, the participant should be better able to:

• Discuss the roles of epithelial cytokine, including TSLP, in the pathogenesis of CRSwNP
• Comprehensively assess patients with CRSwNP for symptom burden, disease phenotypes, and effects on health-related quality of life
• Describe the clinical profiles of current and emerging biologic therapies for patients with CRSwNP
• Individualize treatment regimens for patients with CRSwNP based on symptoms, endotype, treatment goals, and comorbidities

Americans With Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact us prior to the live event at info@exchangecme.com.

Fee Information & Refund/Cancellation Policy

There is no fee for this program.